BCRX insider transactions
BioCryst Pharmaceuticals Inc. (BCRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for BCRX
- Director Milne Jill C. was granted 1,262 shares, increasing direct ownership by 8% to 16,644 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Stonehouse Jon P was granted 631 shares, increasing direct ownership by 0.05% to 1,324,481 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Mckee Amy E was granted 631 shares, increasing direct ownership by 2% to 31,883 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milano Vincent was granted 1,122 shares, increasing direct ownership by 1% to 93,189 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Frank Steven was granted 1,262 shares, increasing direct ownership by 7% to 20,165 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Mckee Amy E sold $100,285 worth of shares (11,180 units at $8.97), decreasing direct ownership by 26% to 31,252 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Legal Officer Barnes Alane P exercised 62,500 shares at a strike of $5.04 and sold $596,250 worth of shares (62,500 units at $9.54) as part of a pre-agreed trading plan (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- SEC Form 4 filed by Menon Sandeep4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- SEC Form 3 filed by new insider Menon Sandeep3 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- SEC Form 4 filed by Heggie Theresa4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- SEC Form 4 filed by Barnes Alane P4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milne Jill C. was granted 528 shares, increasing direct ownership by 4% to 15,382 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Stonehouse Jon P was granted 421 shares, exercised 305,995 shares at a strike of $3.22 and returned $2,643,797 worth of shares to the company (305,995 units at $8.64), increasing direct ownership by 0.03% to 1,323,850 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milano Vincent was granted 848 shares, increasing direct ownership by 0.93% to 92,067 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Frank Steven was granted 1,285 shares, increasing direct ownership by 7% to 18,903 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Mckee Amy E was granted 642 shares, increasing direct ownership by 2% to 42,432 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milne Jill C. was granted 14,854 shares (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- SEC Form 3 filed by new insider Milne Jill C.3 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- New insider Dullinger Ronald claimed ownership of 258,372 shares (SEC Form 3)3 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Executive Officer Stonehouse Jon P covered exercise/tax liability with 61,793 shares, decreasing direct ownership by 4% to 1,323,429 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Legal Officer Barnes Alane P covered exercise/tax liability with 16,902 shares and sold $166,563 worth of shares (21,773 units at $7.65), decreasing direct ownership by 9% to 398,751 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- President and CCO Gayer Charles K covered exercise/tax liability with 11,477 shares and exercised 74,233 shares at a strike of $5.01, increasing direct ownership by 7% to 952,583 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Executive Officer Stonehouse Jon P gifted 20,000 shares and received a gift of 20,000 shares, decreasing direct ownership by 1% to 1,385,222 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- President and CCO Gayer Charles K was granted 471,000 shares, increasing direct ownership by 112% to 889,827 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Legal Officer Barnes Alane P was granted 121,700 shares, increasing direct ownership by 39% to 437,426 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Financial Officer Ghias Babar was granted 121,700 shares, increasing direct ownership by 83% to 268,700 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- President and CCO Gayer Charles K covered exercise/tax liability with 8,181 shares, decreasing direct ownership by 2% to 418,827 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Legal Officer Barnes Alane P covered exercise/tax liability with 8,540 shares and sold $162,256 worth of shares (21,210 units at $7.65), decreasing direct ownership by 9% to 315,726 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Executive Officer Stonehouse Jon P covered exercise/tax liability with 27,368 shares, decreasing direct ownership by 2% to 1,405,222 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Legal Officer Barnes Alane P exercised 91,004 shares at a strike of $3.22 and sold $1,164,967 worth of shares (161,680 units at $7.21), decreasing direct ownership by 17% to 345,476 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Mckee Amy E was granted 783 shares, increasing direct ownership by 2% to 41,790 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Frank Steven was granted 1,566 shares, increasing direct ownership by 10% to 17,618 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milano Vincent was granted 783 shares, increasing direct ownership by 0.87% to 91,219 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Sanders Machelle sold $68,544 worth of shares (9,600 units at $7.14), decreasing direct ownership by 24% to 30,642 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Mckee Amy E was granted 676 shares, increasing direct ownership by 2% to 41,007 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Frank Steven was granted 1,353 shares, increasing direct ownership by 9% to 16,052 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milano Vincent was granted 676 shares, increasing direct ownership by 0.75% to 90,436 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Heggie Theresa exercised 70,000 shares at a strike of $4.34 and sold $595,868 worth of shares (70,000 units at $8.51) (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- CFO & Head of Corp Development Ghias Babar was granted 147,000 shares (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- SEC Form 3 filed by new insider Ghias Babar3 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Sanders Machelle was granted 12,500 shares, increasing direct ownership by 45% to 40,242 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milano Vincent was granted 12,500 shares, increasing direct ownership by 16% to 89,760 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Mckee Amy E was granted 12,500 shares, increasing direct ownership by 45% to 40,331 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Levin Alan G was granted 12,500 shares, increasing direct ownership by 24% to 64,271 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Hutson Nancy J was granted 12,500 shares, increasing direct ownership by 14% to 99,138 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Heggie Theresa was granted 12,500 shares, increasing direct ownership by 24% to 65,352 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Galson Steven K was granted 12,500 shares, increasing direct ownership by 100% to 24,991 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Frank Steven was granted 12,500 shares, increasing direct ownership by 568% to 14,699 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milano Vincent was granted 523 shares, increasing direct ownership by 0.68% to 77,260 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Frank Steven was granted 333 shares, increasing direct ownership by 18% to 2,199 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Frank Steven was granted 1,866 shares (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- SEC Form 3 filed by new insider Frank Steven3 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief R&D Officer Thackray Helen M. covered exercise/tax liability with 7,525 shares, decreasing direct ownership by 2% to 377,318 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Director Milano Vincent was granted 653 shares, increasing direct ownership by 0.86% to 76,737 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Commercial Officer Gayer Charles K was granted 125,950 shares and covered exercise/tax liability with 2,461 shares, increasing direct ownership by 41% to 423,546 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief R&D Officer Thackray Helen M. was granted 125,950 shares and covered exercise/tax liability with 6,096 shares, increasing direct ownership by 45% to 384,843 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Financial Officer Doyle Anthony was granted 120,700 shares and covered exercise/tax liability with 2,461 shares, increasing direct ownership by 46% to 377,867 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Legal Officer Barnes Alane P covered exercise/tax liability with 2,461 shares and was granted 120,700 shares, increasing direct ownership by 40% to 412,729 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- President & CEO Stonehouse Jon P was granted 362,100 shares, covered exercise/tax liability with 14,010 shares, gifted 20,000 shares and received a gift of 20,000 shares, increasing direct ownership by 30% to 1,429,109 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
- Chief Commercial Officer Gayer Charles K covered exercise/tax liability with 8,251 shares, decreasing direct ownership by 3% to 300,057 units (SEC Form 4)4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)